These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 8280698)
61. [Differential diagnosis of pigmented conjunctival changes (light and electron microscopy findings)]. Kulnig W Fortschr Ophthalmol; 1986; 83(1):138-40. PubMed ID: 3519394 [No Abstract] [Full Text] [Related]
62. Boston Ocular Surface Prosthesis for persistent epitheliopathy after treatment of conjunctival melanoma. Grover S; Jacobs DS; Colby KA Cornea; 2010 Apr; 29(4):459-61. PubMed ID: 20164756 [TBL] [Abstract][Full Text] [Related]
63. [Malignant melanoma of the conjunctiva: histopathologic study]. Uffer S Klin Monbl Augenheilkd; 1990 May; 196(5):290-4. PubMed ID: 2366456 [TBL] [Abstract][Full Text] [Related]
64. The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia. Lee JH; Kim YH; Kim MS; Kim EC Semin Ophthalmol; 2014 Jul; 29(4):192-5. PubMed ID: 23971714 [TBL] [Abstract][Full Text] [Related]
65. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution. Hirst LW Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666 [TBL] [Abstract][Full Text] [Related]
66. Epiphora as a side effect of topical mitomycin C. Kopp ED; Seregard S Br J Ophthalmol; 2004 Nov; 88(11):1422-4. PubMed ID: 15489486 [TBL] [Abstract][Full Text] [Related]
67. [Dysontogenetic and melanotic tumors of the conjunctiva]. Völcker HE Fortschr Ophthalmol; 1986; 83(2):163-71. PubMed ID: 3710363 [No Abstract] [Full Text] [Related]
68. Topical medical therapies for ocular surface tumors. Poothullil AM; Colby KA Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014 [TBL] [Abstract][Full Text] [Related]
69. Intralesional mitomycin-C for the treatment of conjunctival Kaposi sarcoma. Korn BS; Park DJ; Kikkawa DO Ophthalmic Plast Reconstr Surg; 2011; 27(4):e88-90. PubMed ID: 21178794 [TBL] [Abstract][Full Text] [Related]
70. Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma. Tunc M; Erbilen E Am J Ophthalmol; 2006 Oct; 142(4):673-5. PubMed ID: 17011863 [TBL] [Abstract][Full Text] [Related]
71. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia. Bahrami B; Greenwell T; Muecke JS Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413 [TBL] [Abstract][Full Text] [Related]
72. [Topical chemotherapy for conjunctival tumours - the medical and legal bearings of the case]. Kempin R; Tost F Klin Monbl Augenheilkd; 2014 Jun; 231(6):594-602. PubMed ID: 24940757 [TBL] [Abstract][Full Text] [Related]
73. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia. Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688 [TBL] [Abstract][Full Text] [Related]
74. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Midena E; Angeli CD; Valenti M; de Belvis V; Boccato P Br J Ophthalmol; 2000 Mar; 84(3):268-72. PubMed ID: 10684836 [TBL] [Abstract][Full Text] [Related]
75. Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias. Kemp EG; Harnett AN; Chatterjee S Br J Ophthalmol; 2002 Jan; 86(1):31-4. PubMed ID: 11801499 [TBL] [Abstract][Full Text] [Related]